Rebound cerebrospinal fluid pleocytosis with elevated cytokine levels during recombinant human granulocyte colony-stimulating factor therapy for purulent meningitis

Pediatrics International

Volumn 41, Issue 3, 1999, Pages 304-306

  Isoyama, Keiichi ^a   Imai, Mitsuru ^a   Yamada, Kouichiro ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Colony stimulating factor; Cytokine; Granulocyte colony stimulating factor therapy; Purulent meningitis

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LATAMOXEF; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; INFANT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; CEREBROSPINAL FLUID; CYTOKINES; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; INFANT, NEWBORN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MENINGITIS, BACTERIAL; NEUTROPHILS; RECURRENCE; SUPPURATION;

EID: 0032977606     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01057.x     Document Type: Article

References (11)

1. 1 Roberts RL, Szelc CM, Scates SM et al. Neutropenia in extremely premature infants treated with recombinant human granulocyte colony-stimulating factor. Am. J. Dis. Child. 1991; 145: 808-12.
2. 2 Cario MS, Suren YU, Knoppel E et al. Decreased G-CSF and IL3 production and gene expression from mononuclear cells ol newborn infants. Pediatr. Res. 1992; 31: 574-8.
3. 3 Wang JM, Chen ZG, Colella S et al. Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 1998; 72: 1456-60.
4. 4 Shimada M, Minato M, Takada M, Takahashi S, Harada K. Plasma concentration of granulocyte colony-stimulating factor in neonates. Acta Paediatr. 1996; 85: 351-5.
5. 5 Eguchi K, Sakaki S, Tamura T et al. Dose escalation study of recombinant human granulocyte colony-stimulating factor (KRN8601) in patients with advanced malignancy. Cancer Res. 1989; 49: 5221-1.
6. 6 Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury, FASEB J. 1994; 8: 504-12.
7. 7 Akopov S, Sercomke R, Seylaz J. Cerebrovascular reactivity: Role of endothelium/platelet/leukocyte interaction. Cerebrovasc. Brain Metah. Rev. 1996; 8: 11-94.
8. 8 Fassbender K, Schminke U, Ragoschke A et al. Endothelial-derived adhesion molecules in bacterial meningitis: Association to cytokine release and intrathecal leukocyte-recruitment. J. Neuroimmunol. 1997; 74: 130-4.
9. 9 Ossege LM, Sindern E, Voss B et al. Expression of tumor necrosis factor-α and transforming growth factor-β 1 in cerebrospinal fluid cells in meningitis. J. Neurol. Sci. 1996; 144: 1-13.
10. 10 Fukushimu K, Ishiguro A, Shimbo T. Transient elevation of granulocyte colony-stimulating factor levels in cerebrospinal fluid at the initial stage of aseptic meningitis in children. Pediatr. Res. 1995; 37: 160-4.
11. 11 Casteels-Van Daele M, Wijndaele L, Hunnick K, Gillis P. Intravenous immune globulin and acute aseptic meningitis. N. Engl. J. Med. 1990; 323: 614-5.